Accessibility Menu
 
Longevity Health logo

Longevity Health

(OTC) XAGE

Current Price$0.35
Market Cap$866,400
Since IPO (2021)-100%
5 YearN/A
1 Year-91%
1 Month+25%

Longevity Health Financials at a Glance

Market Cap

$866,400

Revenue (TTM)

$1.91M

Net Income (TTM)

$6.91M

EPS (TTM)

$-5.08

P/E Ratio

-0.07

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.35

Volume

1,952

Open

$0.37

Previous Close

$0.35

Daily Range

$0.30 - $0.39

52-Week Range

$0.23 - $9.31

XAGE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Longevity Health

Industry

Biotechnology

Employees

10

CEO

Rajiv Sarman Shukla

Headquarters

Pittsburgh, PA 15203, US

XAGE Financials

Key Financial Metrics (TTM)

Gross Margin

57%

Operating Margin

-4%

Net Income Margin

-4%

Return on Equity

0%

Return on Capital

1%

Return on Assets

-3%

Earnings Yield

-14.29%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$866.40K

Shares Outstanding

2.48M

Volume

1.95K

Short Interest

0.00%

Avg. Volume

2.39K

Financials (TTM)

Gross Profit

$1.09M

Operating Income

$7.11M

EBITDA

$6.64M

Operating Cash Flow

$3.33M

Capital Expenditure

$14.22K

Free Cash Flow

$3.34M

Cash & ST Invst.

$706.74K

Total Debt

$499.88K

Longevity Health Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$472.98K

+2606.0%

Gross Profit

$314.90K

+1837.4%

Gross Margin

66.58%

N/A

Market Cap

$866.40K

N/A

Market Cap/Employee

$57.76K

N/A

Employees

15

N/A

Net Income

$2.08M

-127.9%

EBITDA

$1.89M

-95.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$206.86K

+142.9%

Accounts Receivable

$36.50K

-88.1%

Inventory

$963.03K

+785.9%

Long Term Debt

$214.75K

-30.7%

Short Term Debt

$285.13K

-13.3%

Return on Assets

-2.92%

N/A

Return on Invested Capital

1.28%

N/A

Free Cash Flow

$306.37K

+60.3%

Operating Cash Flow

$306.37K

+60.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SCNIScinai Immunotherapeutics Ltd.
$0.58-1.64%
CCMConcord Medical Services Holdings Limited
$3.95+7.63%
HEPAHepion Pharmaceuticals, Inc.
$0.04+18.42%
ZVSAZyVersa Therapeutics, Inc.
$0.20+5.79%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$62.38+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
CRWVCoreWeave
$102.00+0.11%
NOKNokia
$9.46-0.01%

Questions About XAGE

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.